Esophagectomy postallogenic hematopoietic stem cell transplantation for hematologic malignancy: A case series

被引:0
|
作者
Bolger, Jarlath C. [1 ]
Yeung, Jonathan C. [1 ]
机构
[1] Univ Hlth Network, Div Thorac Surg, Toronto, ON, Canada
关键词
D O I
10.1016/j.xjtc.2022.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [31] Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
    Persoon, S.
    Buffart, L. M.
    Chinapaw, M. J. M.
    Nollet, F.
    Frings-Dresen, M. H.
    Koning, S.
    Kersten, M. J.
    Tamminga, S. J.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 2987 - 2997
  • [32] Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation
    Slavin M.A.
    Wolf J.
    Current Infectious Disease Reports, 2009, 11 (6) : 420 - 426
  • [33] Chlorhexidine bathing to reduce CLABSI in hematopoietic stem cell transplant and hematologic malignancy patients
    Reeber, Christina
    Bailey, Kelly
    Nemec, Carrie
    Salata, Robert A.
    Gonzalez, Kathleen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [34] Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
    S. Persoon
    L. M. Buffart
    M. J. M. Chinapaw
    F. Nollet
    M. H. Frings-Dresen
    S. Koning
    M. J. Kersten
    S. J. Tamminga
    Supportive Care in Cancer, 2019, 27 : 2987 - 2997
  • [35] Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation
    Ranganath, Nischal
    Yetmar, Zachary A.
    McCandless, Audrey R.
    Rivera, Christina G.
    Lahr, Brian D.
    Tande, Aaron J.
    Shah, Aditya S.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (05)
  • [36] Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy
    McMilin, KD
    TRANSFUSION, 2002, 42 (04) : 495 - 504
  • [37] Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population
    Morrisette, Taylor
    Van Matre, Amanda G.
    Miller, Matthew A.
    Mueller, Scott W.
    Bajrovic, Valida
    Abidi, Maheen Z.
    Benamu, Esther
    Kaiser, Jeffrey N.
    Barber, Gerard R.
    Chase, Stephanie
    Tobin, Jennifer
    Fish, Douglas N.
    Gutman, Jonathan A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (10) : 2091 - 2097
  • [38] Allogeneic hematopoietic stem cell transplantation increases risk of secondary malignancy
    Nature Clinical Practice Oncology, 2007, 4 (3): : 140 - 141
  • [39] NOVEL INFLUENZA A (H1N1) OUTBREAK IN HEMATOLOGIC MALIGNANCY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) PATIENTS
    Syrigou, A.
    Lalayanni, C.
    Iskas, M.
    Smias, C.
    Kioumis, I.
    Saloum, R.
    Sotiropoulos, D.
    Sakellari, I.
    Anagnostopoulos, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 726 - 727
  • [40] Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation
    Dey, BR
    McAfee, S
    Sackstein, R
    Colby, C
    Saidman, S
    Weymouth, D
    Poliquin, C
    Vanderklish, J
    Sachs, DH
    Sykes, M
    Spitzer, TR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (11) : 604 - 612